
--- Page 1 ---
Sit Frast Nos c s0.9 12.1/1 Procedure Date: Procedure Physician: Attending Physician/Copies To:e UUID:FF6BC87F-029E-4565-A35A-6FB968F8EABA TCGA-BH-A1EU-01A-PR Redacted Patient hIstory: PATH HAS SPECIMEN nnDATE of LMP: DATE OF LAST DELIVERY: PRE-OP DIAQNOSIS: R BREAST CA POST-OP DIAGNOSIS: SAME OPERATIVE PROCEDURE: R SEGM MAST CLINICAL HISTORY: PATH HAS SPECIMEN MATERIAL SUBNITTED:~RIGHT BREAST BIOPSY/MASS/SEGMENTAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURE INTRAOPERATIVE CONSULTATION: cOnsuLt: Right breast: 8.0 by 7.0 by 2.5 cm, with 1.7 by 1.5 by 1.5 cm tumor. All margins grossly negative. ADDENDA: Addendum FINAL DIAGNOSIS: ER/PR DOMUNOPEROXIDASE IDENTIFICATION Or LSTROCEN AND PROGESTERONE RECEPTORS IS CARRIED OUT ON SLIDE SM "A1". DISTINCT INTRANUCLEAR STAINING IS IDENTIFIED FOR LSTROGEN RECEPTOR (9St) AND PROCESTERONE RECEPTOR (9St). THEREFORE, BOTH ARE INTERPRSTED AS POSITIYE HER-2/NEU C-erbB2 (HER-2/NEU) IMMUNOSTAININC IS CARRIED OUT ON MAGEE SURGICAL BLOCK nD2 (BREAST CANCER) USING A 1:3OO DILUTION Or DAKO'S POLYCLONAL ANTIBODY A48S' (DIRECTED AGAINST THE INTRACSLLULAR DCMAIN OF c- GrbB2) WITSOUT ANTIGEN RETRIEVAL. NO DISTINCT CONPLETE MEMBRANE STAINING IS. IDENTIRIED. THEREFORS, C-erbB2 (HER-2/NEU) IS INTERPRETED AS NEGATIVE (SCORE O FINAL DIAGNOSIS: PINAL DIAGNOSIS: RIGHT SEGMENTAL MASTECTOMY: INEILTRATING DUCTAL CARCINOMY, INTERMEDIATE HISTOLOGIC AND NUCLEAR GRADE - NOTTINGHAM SCORE 5 SIZE OF TUMOR 1.7 CM - RETROGRADE EXTENSION INTO LOBULES IS SEEN LYMPHOCYTIC INFILTRATION SEE MICROCALCIFICATIONS - PROLIFERATIVE FIBROCYSTIC CHANGES AND INTRADUCTAL PAPILLOMA SCLEROSING ADENOSISS MARGINS ARE FREE